481 related articles for article (PubMed ID: 19217531)
1. Expressions of glucose transporter Types 1 and 3 and hexokinase-II in diffuse large B-cell lymphoma and other B-cell non-Hodgkin's lymphomas.
Shim HK; Lee WW; Park SY; Kim H; So Y; Kim SE
Nucl Med Biol; 2009 Feb; 36(2):191-7. PubMed ID: 19217531
[TBL] [Abstract][Full Text] [Related]
2. Expression of glucose transporter-1, hexokinase-II, proliferating cell nuclear antigen and survival of patients with pancreatic cancer.
Lyshchik A; Higashi T; Hara T; Nakamoto Y; Fujimoto K; Doi R; Imamura M; Saga T; Togashi K
Cancer Invest; 2007; 25(3):154-62. PubMed ID: 17530485
[TBL] [Abstract][Full Text] [Related]
3. Biologic correlation between glucose transporters, hexokinase-II, Ki-67 and FDG uptake in malignant melanoma.
Park SG; Lee JH; Lee WA; Han KM
Nucl Med Biol; 2012 Nov; 39(8):1167-72. PubMed ID: 22901702
[TBL] [Abstract][Full Text] [Related]
4. FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.
Chung JH; Lee WW; Park SY; Choe G; Sung SW; Chung JK; Lee MC; Kim SE
Eur J Surg Oncol; 2006 Nov; 32(9):989-95. PubMed ID: 16859874
[TBL] [Abstract][Full Text] [Related]
5. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
Nakajo M; Kajiya Y; Tani A; Yoneda S; Shirahama H; Higashi M; Nakajo M
Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
[TBL] [Abstract][Full Text] [Related]
6. Relationship between FDG uptake and expressions of glucose transporter type 1, type 3, and hexokinase-II in Reed-Sternberg cells of Hodgkin lymphoma.
Shim HK; Lee WW; Park SY; Kim H; Kim SE
Oncol Res; 2009; 17(7):331-7. PubMed ID: 19408578
[TBL] [Abstract][Full Text] [Related]
7. CD117 expression in diffuse large B-cell lymphomas: fact or fiction?
Vakiani E; Cattoretti G; Colovai AI; Murty VV; Alobeid B; Bhagat G
Pathol Int; 2005 Nov; 55(11):716-23. PubMed ID: 16271084
[TBL] [Abstract][Full Text] [Related]
8. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Aloj L; Caracó C; Jagoda E; Eckelman WC; Neumann RD
Cancer Res; 1999 Sep; 59(18):4709-14. PubMed ID: 10493529
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin's lymphomas involving the uterus: a clinicopathologic analysis of 26 cases.
Vang R; Medeiros LJ; Ha CS; Deavers M
Mod Pathol; 2000 Jan; 13(1):19-28. PubMed ID: 10658906
[TBL] [Abstract][Full Text] [Related]
10. Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung.
Song YS; Lee WW; Chung JH; Park SY; Kim YK; Kim SE
Lung Cancer; 2008 Jul; 61(1):54-60. PubMed ID: 18191496
[TBL] [Abstract][Full Text] [Related]
11. Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma.
Rodig SJ; Savage KJ; LaCasce AS; Weng AP; Harris NL; Shipp MA; Hsi ED; Gascoyne RD; Kutok JL
Am J Surg Pathol; 2007 Jan; 31(1):106-12. PubMed ID: 17197926
[TBL] [Abstract][Full Text] [Related]
12. Expression of glucose transporters and hexokinase II in cholangiocellular carcinoma compared using [18F]-2-fluro-2-deoxy-D-glucose positron emission tomography.
Paudyal B; Oriuchi N; Paudyal P; Higuchi T; Nakajima T; Endo K
Cancer Sci; 2008 Feb; 99(2):260-6. PubMed ID: 18271924
[TBL] [Abstract][Full Text] [Related]
13. Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
Obermann EC; Went P; Pehrs AC; Tzankov A; Wild PJ; Pileri S; Hofstaedter F; Dirnhofer S
Oncol Rep; 2005 Dec; 14(6):1461-7. PubMed ID: 16273239
[TBL] [Abstract][Full Text] [Related]
14. B-cell differentiation, apoptosis and proliferation in diffuse large B-cell lymphomas.
Bai M; Skyrlas A; Agnantis NJ; Kamina S; Papoudou-Bai A; Kitsoulis P; Kanavaros P
Anticancer Res; 2005; 25(1A):347-62. PubMed ID: 15816558
[TBL] [Abstract][Full Text] [Related]
15. FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models.
Mochizuki T; Tsukamoto E; Kuge Y; Kanegae K; Zhao S; Hikosaka K; Hosokawa M; Kohanawa M; Tamaki N
J Nucl Med; 2001 Oct; 42(10):1551-5. PubMed ID: 11585872
[TBL] [Abstract][Full Text] [Related]
16. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
[TBL] [Abstract][Full Text] [Related]
17. Differential response to H. pylori eradication therapy of co-existing diffuse large B-cell lymphoma and MALT lymphoma of stomach-significance of tumour cell clonality and BCL10 expression.
Kuo SH; Chen LT; Wu MS; Kuo KT; Yeh KH; Doong SL; Yeh PY; Hsu HC; Tzeng YS; Lin CW; Lin JT; Cheng AL
J Pathol; 2007 Feb; 211(3):296-304. PubMed ID: 17167822
[TBL] [Abstract][Full Text] [Related]
18. Relationship between 2-deoxy-2-[(18)F]-fluoro-d-glucose uptake and clinicopathological factors in patients with diffuse large B-cell lymphoma.
Hirose Y; Suefuji H; Kaida H; Hayakawa M; Hattori S; Kurata S; Watanabe Y; Kunou Y; Kawahara A; Okamura T; Ohshima K; Kage M; Ishibashi M; Hayabuchi N
Leuk Lymphoma; 2014 Mar; 55(3):520-5. PubMed ID: 23701133
[TBL] [Abstract][Full Text] [Related]
19. Large B-cell lymphoma with Hodgkin's features.
García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II.
Hamada K; Tomita Y; Qiu Y; Zhang B; Ueda T; Myoui A; Higuchi I; Yoshikawa H; Aozasa K; Hatazawa J
Ann Nucl Med; 2008 Oct; 22(8):699-705. PubMed ID: 18982473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
